3B Blackbio Dx

3BBLACKBIO · NSE

— · —

₹1,622.7

Closing price — 29 Sept 2026

Market cap ₹1,217 Cr · EPS ₹10.26

Valuation

Blended fair value using DCF and peer comparison methods.

See if 3B Blackbio Dx is undervalued

Unlock intrinsic value for 4,800+ Indian stocks — free.

Moderately cyclical company. Peer comparison weighted higher than DCF.

The intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.

Peer comparison

How this company stacks up against sector peers on valuation and quality metrics.

Chemicals · 8 peers · sector medians shown

Better than medianWorse than median

Company	Mkt Cap	P/E	P/B	EV/EBITDA	ROE	Net Margin	Rev CAGR 3y
3B Blackbio Dx 3BBLACKBIO · you	₹1,065 Cr	16.3×	3.0×	17.1×	18.1%	41.3%	31.9%
Sector median	—	27.8×	3.4×	21.0×	9.1%	2.6%	-5.2%
Galaxy Surfactants Limited GALAXYSURF	₹8,112 Cr	27.8×	2.7×	16.2×	9.7%	5.1%	5.5%
Balaji Amines Limited BALAMINES	₹7,745 Cr	40.6×	3.4×	28.2×	8.5%	11.7%	-15.4%
TANFAC Industries Ltd. TANFACIND	₹7,518 Cr	111.2×	28.8×	—	25.9%	0.1%	—
Sharda Cropchem Limited SHARDACROP	₹7,103 Cr	10.1×	3.4×	—	33.4%	0.1%	—
Rain Industries Limited RAIN	₹7,031 Cr	497.7×	7.6×	—	1.5%	0.0%	—
Rashtriya Chemicals and Fertilizers Limited RCF	₹6,846 Cr	15.2×	1.5×	—	9.7%	0.0%	—
Gujarat State Fertilizers & Chemicals Limited GSFC	₹6,295 Cr	9.4×	0.5×	6.2×	5.5%	6.1%	-1.3%
Archean Chemical Industries Limited ACI	₹5,962 Cr	61.5×	3.4×	25.8×	5.5%	9.9%	-9.1%

Peer comparison verdict

3B looks attractively valued — trading at a discount to sector peers on P/E (18.7× vs sector median 27.8×) while delivering above-average returns on equity (18.1% vs 9.1%).

Business quality

Valuation

P/E ratio

18.7×

P/B ratio

—

EV/EBITDA

—

Price/Sales

—

Returns

ROE

18.1%

ROCE

15.1%

ROA

—

Growth

Revenue CAGR (3yr)

31.9%

EPS CAGR (3yr)

31.2%

Efficiency

Asset turnover

—

FCF yield

2.2%

Dividend yield

0.4%

Liquidity & Solvency

Debt / Equity

0.01×

Debt / EBITDA

—

Interest coverage

215.2×

Current ratio

5.27×

Quick ratio

—

Financial health

Piotroski F-Score, Altman Z-Score, and key solvency ratios.

Financial health data is not yet available for this company.

Full financial data

Charts and annual statements for income, balance sheet and cash flow.

Income trend

Revenue, profit and margin trends over time.

Revenue

Net profit

Operating margin

Net margin

Revenue

₹142 Cr

Net profit

₹59 Cr

Operating margin

—

Net margin

41.3%

Revenue and net profit in ₹ Crores (left axis). Margins % on right axis.

Cash flow

Where cash comes from and where it goes.

Operating CFInvesting CFFinancing CFFree cash flow

Operating CF — Cash earned from running the business. The core engine of financial health.

Investing CF — Cash spent on assets and equipment. Negative is normal — it means the company is investing in growth.

Financing CF — Cash from borrowing or repaying loans and dividends. Negative means debt is being repaid.

Free cash flow — Operating CF minus capex. Cash left after keeping the business running. Positive and growing is ideal.

Operating CF

₹52.48 Cr

Investing CF

₹0 Cr

Financing CF

₹0 Cr

Free cash flow

₹26.97 Cr

Balance sheet

Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.

How the company is funded — equity is owners' money, debt is long-term borrowing, current liabilities are short-term obligations.

Equity

Debt

Current liabilities

Total assets

—

Total debt

₹3 Cr

Equity

₹324 Cr

Debt / Equity

0.01×

Numbers are illustrative — order-of-magnitude correct. For precise figures, refer to the company's annual report on BSE/NSE.

Shareholding pattern

Who owns this company and how that has changed.

What shareholding tells you: When promoters (founders/controlling shareholders) increase their stake, it usually signals confidence in the business. Rising FII (foreign funds) interest means international money is moving in. High promoter pledge is a risk — pledged shares can be force-sold if the stock price falls sharply.

Latest quarter

Promoter

40.9%

-0.3 pp QoQ

FII

2.6%

DII

2.0%

+0.1 pp QoQ

Retail

54.5%

Trend over time (%)

Quarterly data

Category	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Change (YoY)
Promoter	38.4%	38.4%	38.4%	41.3%	41.3%	41.3%	41.3%	41.3%	41.3%	41.3%	41.3%	40.9%	-0.3 ppYoY
FII (Foreign)	3.1%	3.2%	3.4%	3.0%	3.3%	3.3%	2.7%	2.5%	2.7%	2.6%	2.6%	2.6%	+0.1 ppYoY
DII (Domestic)	0.0%	0.8%	1.2%	1.9%	2.0%	2.0%	1.7%	1.6%	1.8%	1.8%	1.9%	2.0%	+0.4 ppYoY
Retail	58.5%	57.6%	57.0%	53.9%	53.5%	53.5%	54.3%	54.6%	54.3%	54.3%	54.3%	54.5%	-0.1 ppYoY

Signals from the trend

📈

PromoterUp 2.5pp — insiders are adding to their stake

📉

FIINet sellers (0.5pp) — foreign institutional interest is declining

📈

DIINet buyers (+2pp) — domestic funds are accumulating

Mixed signals — promoter buying and DII buying on the positive side, but FII outflows adds uncertainty.

pp = percentage points. FII = Foreign Institutional Investors. DII = Domestic Institutional Investors (MFs, insurance). Data sourced from NSE/BSE filings. Verify on BSE/NSE before any investment decision.